<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29200750</article-id><article-id pub-id-type="pmc">5688834</article-id><article-id pub-id-type="publisher-id">AYU-37-120</article-id><article-id pub-id-type="doi">10.4103/ayu.AYU_211_15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparative study of <italic>Shilajatu</italic> and <italic>Asanadi Ghana Vati</italic> in the management of <italic>Madhumeha</italic> w.s.r. to type-2 diabetes mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Vandana</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Keshari</surname><given-names>Bipin Bihari</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Tiwari</surname><given-names>S. K.</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Murthy</surname><given-names>K. H. H. V. S. S. Narasimha</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Department of Kayachikitsa, VYDS Ayurvedic College, Khurja, Uttar Pradesh, India</aff><aff id="aff2"><label>1</label>Department of Maulika Sidhanta, VYDS Ayurvedic College, Khurja, Uttar Pradesh, India</aff><aff id="aff3"><label>2</label>Department of Kayachikitsa, Faculty of Ayurveda, IMS Banaras Hindu University, Varanasi, Uttar Pradesh, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence</bold>: Dr. Bipin Bihari Keshari, Department of Maulika Sidhanta, VYDS Ayurvedic College, Khurja - 203131, Uttar Pradesh, India. E-mail: <email xlink:href="doc.vipinkesarwani@gmail.com">doc.vipinkesarwani@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2016</year></pub-date><volume>37</volume><issue>2</issue><fpage>120</fpage><lpage>124</lpage><permissions><copyright-statement>Copyright: © 2017 AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3417" xml_f="3430" txt_i="11" txt_f="24">Introduction:</offsets></title><p><offsets xml_i="3441" xml_f="3628" txt_i="25" txt_f="212">Diabetes mellitus is becoming an alarming problem for society nowadays causing impediment in normal life. Diabetes and its complications impose a major burden upon health-care facilities.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3659" xml_f="3681" txt_i="214" txt_f="236">Materials and Methods:</offsets></title><p><offsets xml_i="3692" xml_f="3722" txt_i="237" txt_f="267">In this study, 90 patients of </offsets><italic><offsets xml_i="3730" xml_f="3739" txt_i="267" txt_f="276">Madhumeha</offsets></italic><offsets xml_i="3748" xml_f="3915" txt_i="276" txt_f="443"> (type-2 diabetes mellitus) were registered and randomly divided into two groups. Out of 90 registered patients, 80 patients completed the treatment. In Group A, cap. </offsets><italic><offsets xml_i="3923" xml_f="3932" txt_i="443" txt_f="452">Shilajatu</offsets></italic><offsets xml_i="3941" xml_f="4002" txt_i="452" txt_f="513"> (500 mg twice daily) was given for 3 months and in Group B, </offsets><italic><offsets xml_i="4010" xml_f="4028" txt_i="513" txt_f="531">Asanadi Ghana Vati</offsets></italic><offsets xml_i="4037" xml_f="4041" txt_i="531" txt_f="535"> (2 </offsets><italic><offsets xml_i="4049" xml_f="4053" txt_i="535" txt_f="539">Vati</offsets></italic><offsets xml_i="4062" xml_f="4099" txt_i="539" txt_f="576"> twice daily) was given for 3 months.</offsets></p></sec><sec id="st3"><title><offsets xml_i="4130" xml_f="4134" txt_i="578" txt_f="582">Aim:</offsets></title><p><offsets xml_i="4145" xml_f="4205" txt_i="583" txt_f="643">An attempt was made to evaluate and compare the efficacy of </offsets><italic><offsets xml_i="4213" xml_f="4222" txt_i="643" txt_f="652">Shilajatu</offsets></italic><offsets xml_i="4231" xml_f="4236" txt_i="652" txt_f="657"> and </offsets><italic><offsets xml_i="4244" xml_f="4262" txt_i="657" txt_f="675">Asanadi Ghana Vati</offsets></italic><offsets xml_i="4271" xml_f="4473" txt_i="675" txt_f="877"> in the management of type-2 diabetes mellitus. The efficacy of therapy was assessed on the basis of improvement in sign and symptoms of diabetes mellitus, blood sugar level, and glycosylated hemoglobin</offsets></p></sec><sec id="st4"><title><offsets xml_i="4504" xml_f="4512" txt_i="879" txt_f="887">Results:</offsets></title><p><offsets xml_i="4523" xml_f="4676" txt_i="888" txt_f="1041">Statistically significant improvement was observed in sign and symptoms as well as on blood sugar level in both groups after the completion of treatment.</offsets></p></sec><sec id="st5"><title><offsets xml_i="4707" xml_f="4718" txt_i="1043" txt_f="1054">Conclusion:</offsets></title><p><italic><offsets xml_i="4737" xml_f="4746" txt_i="1055" txt_f="1064">Shilajatu</offsets></italic><offsets xml_i="4755" xml_f="4760" txt_i="1064" txt_f="1069"> and </offsets><italic><offsets xml_i="4768" xml_f="4786" txt_i="1069" txt_f="1087">Asanadi Ghana Vati</offsets></italic><offsets xml_i="4795" xml_f="4859" txt_i="1087" txt_f="1151"> seem to be effective and completely safe for the management of </offsets><italic><offsets xml_i="4867" xml_f="4876" txt_i="1151" txt_f="1160">Madhumeha</offsets></italic><offsets xml_i="4885" xml_f="4913" txt_i="1160" txt_f="1188"> (type-2 diabetes mellitus).</offsets></p></sec></abstract><kwd-group><kwd><italic>Asanadi Ghana Vati</italic></kwd><kwd>diabetes mellitus</kwd><kwd><italic>Madhumeha</italic></kwd><kwd><italic>Shilajatu</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5175" xml_f="5187" txt_i="1197" txt_f="1209">Introduction</offsets></title><p><offsets xml_i="5198" xml_f="6155" txt_i="1210" txt_f="2167">Diabetes mellitus is a syndrome characterized by disordered metabolism and hyperglycemia either due to the deficiency of insulin secretion or due to the combination of insulin resistance and inadequate insulin secretion. Type-1 diabetes is due to the destruction of pancreatic islet beta cells predominantly by an autoimmune process and these patients are prone to ketoacidosis. Type-2 diabetes is the more prevalent form and results from insulin resistance with a defect in compensatory insulin secretion. Many patients with type-2 diabetes have an insidious onset of hyperglycemia and remain asymptomatic for longer period. Hence, many individuals with type-2 diabetes mellitus have complications at the time of presentation. Diabetes is now the leading cause of blindness, neuropathy, end-stage renal disease, and nontraumatic leg amputation. In addition, morbidity and mortality due to adverse cardiac events and stroke are also very common in diabetes.</offsets></p><p><offsets xml_i="6162" xml_f="6682" txt_i="2168" txt_f="2688">Currently, a number of antidiabetic agents such as oral hypoglycemic agents and various insulin preparations are available for the management of diabetes, but their long-term applications cause various adverse effects. Therefore, the search for effective and safer drugs to manage hyperglycemia is one of the important areas of research. In Ayurveda, many plants and plant-based medications have been advocated for the management of diabetes since time immemorial. In the present study, the classical herbomineral drug, </offsets><italic><offsets xml_i="6690" xml_f="6699" txt_i="2688" txt_f="2697">Shilajatu</offsets></italic><offsets xml_i="6708" xml_f="6710" txt_i="2697" txt_f="2699"> (</offsets><italic><offsets xml_i="6718" xml_f="6737" txt_i="2699" txt_f="2718">Asphaltumpunjabinum</offsets></italic><offsets xml_i="6746" xml_f="6752" txt_i="2718" txt_f="2724">) and </offsets><italic><offsets xml_i="6760" xml_f="6779" txt_i="2724" txt_f="2743">Asanadi Gana Dravya</offsets></italic><offsets xml_i="6788" xml_f="6830" txt_i="2743" txt_f="2785">, has been selected for the management of </offsets><italic><offsets xml_i="6838" xml_f="6847" txt_i="2785" txt_f="2794">Madhumeha</offsets></italic><offsets xml_i="6856" xml_f="6908" txt_i="2794" txt_f="2846"> (type-2 diabetes mellitus). In Ayurvedic classics, </offsets><italic><offsets xml_i="6916" xml_f="6925" txt_i="2846" txt_f="2855">Shilajatu</offsets></italic><offsets xml_i="6934" xml_f="6951" txt_i="2855" txt_f="2872"> is described as </offsets><italic><offsets xml_i="6959" xml_f="6978" txt_i="2872" txt_f="2891">Naimittika Rasayana</offsets></italic><offsets xml_i="6987" xml_f="6992" txt_i="2891" txt_f="2896"> for </offsets><italic><offsets xml_i="7000" xml_f="7007" txt_i="2896" txt_f="2903">Prameha</offsets></italic><offsets xml_i="7016" xml_f="7018" txt_i="2903" txt_f="2905">. </offsets><italic><offsets xml_i="7026" xml_f="7038" txt_i="2905" txt_f="2917">Asanadi Gana</offsets></italic><offsets xml_i="7047" xml_f="7070" txt_i="2917" txt_f="2940"> has been described in </offsets><italic><offsets xml_i="7078" xml_f="7095" txt_i="2940" txt_f="2957">Ashtanga Samgraha</offsets></italic><offsets xml_i="7104" xml_f="7105" txt_i="2957" txt_f="2958">[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="7138" xml_f="7139" txt_i="2958" txt_f="2959">1</offsets></xref><offsets xml_i="7146" xml_f="7152" txt_i="2959" txt_f="2965">] and </offsets><italic><offsets xml_i="7160" xml_f="7176" txt_i="2965" txt_f="2981">Ashtanga Hridaya</offsets></italic><offsets xml_i="7185" xml_f="7186" txt_i="2981" txt_f="2982">[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="7219" xml_f="7220" txt_i="2982" txt_f="2983">2</offsets></xref><offsets xml_i="7227" xml_f="7250" txt_i="2983" txt_f="3006">] for the treatment of </offsets><italic><offsets xml_i="7258" xml_f="7265" txt_i="3006" txt_f="3013">Shwitra</offsets></italic><offsets xml_i="7274" xml_f="7276" txt_i="3013" txt_f="3015">, </offsets><italic><offsets xml_i="7284" xml_f="7291" txt_i="3015" txt_f="3022">Kushtha</offsets></italic><offsets xml_i="7300" xml_f="7302" txt_i="3022" txt_f="3024">, </offsets><italic><offsets xml_i="7310" xml_f="7324" txt_i="3024" txt_f="3038">Kaphaja-Vikara</offsets></italic><offsets xml_i="7333" xml_f="7335" txt_i="3038" txt_f="3040">, </offsets><italic><offsets xml_i="7343" xml_f="7348" txt_i="3040" txt_f="3045">Krimi</offsets></italic><offsets xml_i="7357" xml_f="7359" txt_i="3045" txt_f="3047">, </offsets><italic><offsets xml_i="7367" xml_f="7376" txt_i="3047" txt_f="3056">Panduroga</offsets></italic><offsets xml_i="7385" xml_f="7387" txt_i="3056" txt_f="3058">, </offsets><italic><offsets xml_i="7395" xml_f="7402" txt_i="3058" txt_f="3065">Prameha</offsets></italic><offsets xml_i="7411" xml_f="7413" txt_i="3065" txt_f="3067">, </offsets><italic><offsets xml_i="7421" xml_f="7434" txt_i="3067" txt_f="3080">and Medodosha</offsets></italic><offsets xml_i="7443" xml_f="7464" txt_i="3080" txt_f="3101">. The ingredients of </offsets><italic><offsets xml_i="7472" xml_f="7484" txt_i="3101" txt_f="3113">Asanadi Gana</offsets></italic><offsets xml_i="7493" xml_f="7498" txt_i="3113" txt_f="3118"> are </offsets><italic><offsets xml_i="7506" xml_f="7511" txt_i="3118" txt_f="3123">Asana</offsets></italic><offsets xml_i="7520" xml_f="7522" txt_i="3123" txt_f="3125"> (</offsets><italic><offsets xml_i="7530" xml_f="7551" txt_i="3125" txt_f="3146">Pterocarpus marsupium</offsets></italic><offsets xml_i="7560" xml_f="7569" txt_i="3146" txt_f="3155"> Roxb.), </offsets><italic><offsets xml_i="7577" xml_f="7584" txt_i="3155" txt_f="3162">Tinisha</offsets></italic><offsets xml_i="7593" xml_f="7595" txt_i="3162" txt_f="3164"> (</offsets><italic><offsets xml_i="7603" xml_f="7623" txt_i="3164" txt_f="3184">Ougeinia oojeinensis</offsets></italic><offsets xml_i="7632" xml_f="7641" txt_i="3184" txt_f="3193"> Roxb.), </offsets><italic><offsets xml_i="7649" xml_f="7658" txt_i="3193" txt_f="3202">Bhojpatra</offsets></italic><offsets xml_i="7667" xml_f="7669" txt_i="3202" txt_f="3204"> (</offsets><italic><offsets xml_i="7677" xml_f="7689" txt_i="3204" txt_f="3216">Betulautilis</offsets></italic><offsets xml_i="7698" xml_f="7709" txt_i="3216" txt_f="3227"> D. Don.), </offsets><italic><offsets xml_i="7717" xml_f="7727" txt_i="3227" txt_f="3237">Shwetawaha</offsets></italic><offsets xml_i="7736" xml_f="7738" txt_i="3237" txt_f="3239"> (</offsets><italic><offsets xml_i="7746" xml_f="7763" txt_i="3239" txt_f="3256">Terminalia arjuna</offsets></italic><offsets xml_i="7772" xml_f="7781" txt_i="3256" txt_f="3265"> Roxb.), </offsets><italic><offsets xml_i="7789" xml_f="7797" txt_i="3265" txt_f="3273">Prakirya</offsets></italic><offsets xml_i="7806" xml_f="7808" txt_i="3273" txt_f="3275"> (</offsets><italic><offsets xml_i="7816" xml_f="7839" txt_i="3275" txt_f="3298">Holoptelea integrifolia</offsets></italic><offsets xml_i="7848" xml_f="7859" txt_i="3298" txt_f="3309"> Planch.), </offsets><italic><offsets xml_i="7867" xml_f="7874" txt_i="3309" txt_f="3316">Khadira</offsets></italic><offsets xml_i="7883" xml_f="7885" txt_i="3316" txt_f="3318"> (</offsets><italic><offsets xml_i="7893" xml_f="7907" txt_i="3318" txt_f="3332">Acacia catechu</offsets></italic><offsets xml_i="7916" xml_f="7924" txt_i="3332" txt_f="3340"> Wild), </offsets><italic><offsets xml_i="7932" xml_f="7938" txt_i="3340" txt_f="3346">Kadara</offsets></italic><offsets xml_i="7947" xml_f="7949" txt_i="3346" txt_f="3348"> (</offsets><italic><offsets xml_i="7957" xml_f="7968" txt_i="3348" txt_f="3359">Acacia suma</offsets></italic><offsets xml_i="7977" xml_f="7984" txt_i="3359" txt_f="3366"> Ham), </offsets><italic><offsets xml_i="7992" xml_f="7998" txt_i="3366" txt_f="3372">Bhandi</offsets></italic><offsets xml_i="8007" xml_f="8009" txt_i="3372" txt_f="3374"> (</offsets><italic><offsets xml_i="8017" xml_f="8032" txt_i="3374" txt_f="3389">Albizia lebbeck</offsets></italic><offsets xml_i="8041" xml_f="8051" txt_i="3389" txt_f="3399"> Benth.), </offsets><italic><offsets xml_i="8059" xml_f="8068" txt_i="3399" txt_f="3408">Shimshapa</offsets></italic><offsets xml_i="8077" xml_f="8079" txt_i="3408" txt_f="3410"> (</offsets><italic><offsets xml_i="8087" xml_f="8103" txt_i="3410" txt_f="3426">Dalbergia sissoo</offsets></italic><offsets xml_i="8112" xml_f="8121" txt_i="3426" txt_f="3435"> Roxb.), </offsets><italic><offsets xml_i="8129" xml_f="8141" txt_i="3435" txt_f="3447">Meshashringi</offsets></italic><offsets xml_i="8150" xml_f="8152" txt_i="3447" txt_f="3449"> (</offsets><italic><offsets xml_i="8160" xml_f="8177" txt_i="3449" txt_f="3466">Gymnema sylvestre</offsets></italic><offsets xml_i="8186" xml_f="8206" txt_i="3466" txt_f="3486"> R. Br.), the three </offsets><italic><offsets xml_i="8214" xml_f="8218" txt_i="3486" txt_f="3490">Hima</offsets></italic><offsets xml_i="8227" xml_f="8234" txt_i="3490" txt_f="3497">, i.e. </offsets><italic><offsets xml_i="8242" xml_f="8257" txt_i="3497" txt_f="3512">Shweta Chandana</offsets></italic><offsets xml_i="8266" xml_f="8268" txt_i="3512" txt_f="3514"> (</offsets><italic><offsets xml_i="8276" xml_f="8290" txt_i="3514" txt_f="3528">Santalum album</offsets></italic><offsets xml_i="8299" xml_f="8308" txt_i="3528" txt_f="3537"> Linn.), </offsets><italic><offsets xml_i="8316" xml_f="8329" txt_i="3537" txt_f="3550">Raktachandana</offsets></italic><offsets xml_i="8338" xml_f="8340" txt_i="3550" txt_f="3552"> (</offsets><italic><offsets xml_i="8348" xml_f="8370" txt_i="3552" txt_f="3574">Pterocarpus santalinus</offsets></italic><offsets xml_i="8379" xml_f="8392" txt_i="3574" txt_f="3587"> Linn.), and </offsets><italic><offsets xml_i="8400" xml_f="8411" txt_i="3587" txt_f="3598">Daruharidra</offsets></italic><offsets xml_i="8420" xml_f="8422" txt_i="3598" txt_f="3600"> (</offsets><italic><offsets xml_i="8430" xml_f="8447" txt_i="3600" txt_f="3617">Berberis aristata</offsets></italic><offsets xml_i="8456" xml_f="8463" txt_i="3617" txt_f="3624"> DC.), </offsets><italic><offsets xml_i="8471" xml_f="8475" txt_i="3624" txt_f="3628">Tala</offsets></italic><offsets xml_i="8484" xml_f="8486" txt_i="3628" txt_f="3630"> (</offsets><italic><offsets xml_i="8494" xml_f="8514" txt_i="3630" txt_f="3650">Borassus flabellifer</offsets></italic><offsets xml_i="8523" xml_f="8532" txt_i="3650" txt_f="3659"> Linn.), </offsets><italic><offsets xml_i="8540" xml_f="8547" txt_i="3659" txt_f="3666">Palasha</offsets></italic><offsets xml_i="8556" xml_f="8558" txt_i="3666" txt_f="3668"> (</offsets><italic><offsets xml_i="8566" xml_f="8582" txt_i="3668" txt_f="3684">Butea monosperma</offsets></italic><offsets xml_i="8591" xml_f="8599" txt_i="3684" txt_f="3692"> Lam.), </offsets><italic><offsets xml_i="8607" xml_f="8612" txt_i="3692" txt_f="3697">Agaru</offsets></italic><offsets xml_i="8621" xml_f="8623" txt_i="3697" txt_f="3699"> (</offsets><italic><offsets xml_i="8631" xml_f="8651" txt_i="3699" txt_f="3719">Aquillaria agallocha</offsets></italic><offsets xml_i="8660" xml_f="8669" txt_i="3719" txt_f="3728"> Roxb.), </offsets><italic><offsets xml_i="8677" xml_f="8682" txt_i="3728" txt_f="3733">Shaka</offsets></italic><offsets xml_i="8691" xml_f="8693" txt_i="3733" txt_f="3735"> (</offsets><italic><offsets xml_i="8701" xml_f="8716" txt_i="3735" txt_f="3750">Tectona grandis</offsets></italic><offsets xml_i="8725" xml_f="8734" txt_i="3750" txt_f="3759"> Linn.), </offsets><italic><offsets xml_i="8742" xml_f="8747" txt_i="3759" txt_f="3764">Shala</offsets></italic><offsets xml_i="8756" xml_f="8758" txt_i="3764" txt_f="3766"> (</offsets><italic><offsets xml_i="8766" xml_f="8780" txt_i="3766" txt_f="3780">Shorea robusta</offsets></italic><offsets xml_i="8789" xml_f="8800" txt_i="3780" txt_f="3791"> Gaertn.), </offsets><italic><offsets xml_i="8808" xml_f="8813" txt_i="3791" txt_f="3796">Dhava</offsets></italic><offsets xml_i="8822" xml_f="8824" txt_i="3796" txt_f="3798"> (</offsets><italic><offsets xml_i="8832" xml_f="8852" txt_i="3798" txt_f="3818">Anogeissus latifolia</offsets></italic><offsets xml_i="8861" xml_f="8870" txt_i="3818" txt_f="3827"> Wall.), </offsets><italic><offsets xml_i="8878" xml_f="8885" txt_i="3827" txt_f="3834">Kramuka</offsets></italic><offsets xml_i="8894" xml_f="8896" txt_i="3834" txt_f="3836"> (</offsets><italic><offsets xml_i="8904" xml_f="8917" txt_i="3836" txt_f="3849">Areca catechu</offsets></italic><offsets xml_i="8926" xml_f="8935" txt_i="3849" txt_f="3858"> Linn.), </offsets><italic><offsets xml_i="8943" xml_f="8952" txt_i="3858" txt_f="3867">Indrayava</offsets></italic><offsets xml_i="8961" xml_f="8963" txt_i="3867" txt_f="3869"> (</offsets><italic><offsets xml_i="8971" xml_f="8997" txt_i="3869" txt_f="3895">Holarrhena antidysenterica</offsets></italic><offsets xml_i="9006" xml_f="9015" txt_i="3895" txt_f="3904"> Linn.), </offsets><italic><offsets xml_i="9023" xml_f="9033" txt_i="3904" txt_f="3914">Chagakarna</offsets></italic><offsets xml_i="9042" xml_f="9044" txt_i="3914" txt_f="3916"> (</offsets><italic><offsets xml_i="9052" xml_f="9066" txt_i="3916" txt_f="3930">Vateria indica</offsets></italic><offsets xml_i="9075" xml_f="9087" txt_i="3930" txt_f="3942"> Linn), and </offsets><italic><offsets xml_i="9095" xml_f="9105" txt_i="3942" txt_f="3952">Ashwakarna</offsets></italic><offsets xml_i="9114" xml_f="9116" txt_i="3952" txt_f="3954"> (</offsets><italic><offsets xml_i="9124" xml_f="9144" txt_i="3954" txt_f="3974">Dipterocarpus alatus</offsets></italic><offsets xml_i="9153" xml_f="9155" txt_i="3974" txt_f="3976">).</offsets></p><p><offsets xml_i="9162" xml_f="9222" txt_i="3977" txt_f="4037">The present study was carried out to assess the efficacy of </offsets><italic><offsets xml_i="9230" xml_f="9239" txt_i="4037" txt_f="4046">Shilajatu</offsets></italic><offsets xml_i="9248" xml_f="9253" txt_i="4046" txt_f="4051"> and </offsets><italic><offsets xml_i="9261" xml_f="9279" txt_i="4051" txt_f="4069">Asanadi Ghana Vati</offsets></italic><offsets xml_i="9288" xml_f="9310" txt_i="4069" txt_f="4091"> in the management of </offsets><italic><offsets xml_i="9318" xml_f="9327" txt_i="4091" txt_f="4100">Madhumeha</offsets></italic><offsets xml_i="9336" xml_f="9390" txt_i="4100" txt_f="4154"> (type-2 diabetes mellitus) and compare the effect of </offsets><italic><offsets xml_i="9398" xml_f="9407" txt_i="4154" txt_f="4163">Shilajatu</offsets></italic><offsets xml_i="9416" xml_f="9421" txt_i="4163" txt_f="4168"> and </offsets><italic><offsets xml_i="9429" xml_f="9447" txt_i="4168" txt_f="4186">Asanadi Ghana Vati</offsets></italic><offsets xml_i="9456" xml_f="9478" txt_i="4186" txt_f="4208"> in the management of </offsets><italic><offsets xml_i="9486" xml_f="9495" txt_i="4208" txt_f="4217">Madhumeha</offsets></italic><offsets xml_i="9504" xml_f="9505" txt_i="4217" txt_f="4218">.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="9568" xml_f="9589" txt_i="4220" txt_f="4241">Materials and Methods</offsets></title><p><offsets xml_i="9600" xml_f="9653" txt_i="4242" txt_f="4295">Ninety patients with classical signs and symptoms of </offsets><italic><offsets xml_i="9661" xml_f="9670" txt_i="4295" txt_f="4304">Madhumeha</offsets></italic><offsets xml_i="9679" xml_f="9900" txt_i="4304" txt_f="4525"> (type-2 diabetes mellitus) were selected from the OPD and IPD of Department of Kayachikitsa, IMS Banaras Hindu University. The research protocol was approved by the Institutional Ethical committee (No. Dean/2012-13/125).</offsets></p><p><offsets xml_i="9907" xml_f="9982" txt_i="4526" txt_f="4601">A proforma including classical signs and symptoms of diabetes mellitus and </offsets><italic><offsets xml_i="9990" xml_f="10009" txt_i="4601" txt_f="4620">Srotodusti Lakshana</offsets></italic><offsets xml_i="10018" xml_f="10200" txt_i="4620" txt_f="4802"> was made for assessing all the patients. The patients were properly interrogated and examined on the basis of proforma, and laboratory investigations were carried out for diagnosis.</offsets></p><sec id="sec2-1"><title><offsets xml_i="10228" xml_f="10246" txt_i="4803" txt_f="4821">Inclusion criteria</offsets></title><p><offsets xml_i="10257" xml_f="10258" txt_i="4822" txt_f="4823">
</offsets><list list-type="order"><list-item><p><offsets xml_i="10296" xml_f="10345" txt_i="4823" txt_f="4872">Fasting plasma glucose ≥126 mg/dL up to 250 mg/dl</offsets></p></list-item><list-item><p><offsets xml_i="10375" xml_f="10462" txt_i="4873" txt_f="4960">2-h plasma glucose ≥200 mg/dl and up to 350 mg/dl during an oral glucose tolerance test</offsets></p></list-item><list-item><p><offsets xml_i="10492" xml_f="10569" txt_i="4961" txt_f="5038">Symptoms of diabetes plus random blood glucose ≥200 mg/dl and up to 350 mg/dl</offsets></p></list-item><list-item><p><offsets xml_i="10599" xml_f="10634" txt_i="5039" txt_f="5074">Patients in between 30 and 80 years</offsets></p></list-item><list-item><p><offsets xml_i="10664" xml_f="10716" txt_i="5075" txt_f="5127">Patients having complication of diabetic neuropathy.</offsets></p></list-item></list><offsets xml_i="10739" xml_f="10740" txt_i="5128" txt_f="5129">
</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="10774" xml_f="10792" txt_i="5131" txt_f="5149">Exclusion criteria</offsets></title><p><offsets xml_i="10803" xml_f="10804" txt_i="5150" txt_f="5151">
</offsets><list list-type="order"><list-item><p><offsets xml_i="10842" xml_f="10884" txt_i="5151" txt_f="5193">Patients of type-1 diabetes mellitus cases</offsets></p></list-item><list-item><p><offsets xml_i="10914" xml_f="11007" txt_i="5194" txt_f="5287">Cases with severe diabetic complications such as cardiac disease, nephropathy, and foot ulcer</offsets></p></list-item><list-item><p><offsets xml_i="11037" xml_f="11149" txt_i="5288" txt_f="5400">Patients with chronic diseases such as tuberculosis, bronchial asthma, chronic renal failure, HIV, and hepatitis</offsets></p></list-item><list-item><p><offsets xml_i="11179" xml_f="11220" txt_i="5401" txt_f="5442">Patient below 30 years and above 80 years</offsets></p></list-item><list-item><p><offsets xml_i="11250" xml_f="11285" txt_i="5443" txt_f="5478">Patients on corticosteroid therapy.</offsets></p></list-item></list><offsets xml_i="11308" xml_f="11309" txt_i="5479" txt_f="5480">
</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="11343" xml_f="11356" txt_i="5482" txt_f="5495">Plan of study</offsets></title><p><offsets xml_i="11367" xml_f="11422" txt_i="5496" txt_f="5551">Ninety patients having classical signs and symptoms of </offsets><italic><offsets xml_i="11430" xml_f="11439" txt_i="5551" txt_f="5560">Madhumeha</offsets></italic><offsets xml_i="11448" xml_f="11753" txt_i="5560" txt_f="5865"> (type-2 diabetes mellitus) were selected for the study on the basis of inclusion and exclusion criteria and investigations done. Out of 90 registered patients, 80 patients could complete the study and 10 patients discontinued the treatment. 80 patients of the study were randomly divided into two groups:</offsets></p><p><offsets xml_i="11760" xml_f="11761" txt_i="5866" txt_f="5867">
</offsets><list list-type="bullet"><list-item><p><offsets xml_i="11800" xml_f="11872" txt_i="5867" txt_f="5939">Group A: 40 cases of type-2 diabetes mellitus were advised to take cap. </offsets><italic><offsets xml_i="11880" xml_f="11889" txt_i="5939" txt_f="5948">Shilajatu</offsets></italic><offsets xml_i="11898" xml_f="11993" txt_i="5948" txt_f="6043">, 1BD (each cap. 500 mg) for 3 months (divided into three follow-ups, each of 1 month interval)</offsets></p></list-item><list-item><p><offsets xml_i="12023" xml_f="12090" txt_i="6044" txt_f="6111">Group B: 40 cases of type-2 diabetes mellitus were advised to take </offsets><italic><offsets xml_i="12098" xml_f="12116" txt_i="6111" txt_f="6129">Asanadi Ghana Vati</offsets></italic><offsets xml_i="12125" xml_f="12138" txt_i="6129" txt_f="6142">, 2 BD (each </offsets><italic><offsets xml_i="12146" xml_f="12150" txt_i="6142" txt_f="6146">Vati</offsets></italic><offsets xml_i="12159" xml_f="12239" txt_i="6146" txt_f="6226"> 500 mg) for 3 months (divided into three follow-ups, each of 1 month interval).</offsets></p></list-item></list><offsets xml_i="12262" xml_f="12263" txt_i="6227" txt_f="6228">
</offsets></p></sec><sec id="sec2-4"><title><offsets xml_i="12297" xml_f="12310" txt_i="6230" txt_f="6243">Investigation</offsets></title><p><offsets xml_i="12321" xml_f="12407" txt_i="6244" txt_f="6330">Following investigations were carried out to assess the efficacy of trial drugs (cap. </offsets><italic><offsets xml_i="12415" xml_f="12424" txt_i="6330" txt_f="6339">Shilajatu</offsets></italic><offsets xml_i="12433" xml_f="12438" txt_i="6339" txt_f="6344"> and </offsets><italic><offsets xml_i="12446" xml_f="12464" txt_i="6344" txt_f="6362">Asanadi Ghana vati</offsets></italic><offsets xml_i="12473" xml_f="12514" txt_i="6362" txt_f="6403">) and to find any other systemic disease:</offsets></p><p><offsets xml_i="12521" xml_f="12522" txt_i="6404" txt_f="6405">
</offsets><list list-type="bullet"><list-item><p><offsets xml_i="12561" xml_f="12622" txt_i="6405" txt_f="6466">Fasting blood sugar (FBS) and postprandial blood sugar (PPBS)</offsets></p></list-item><list-item><p><offsets xml_i="12652" xml_f="12682" txt_i="6467" txt_f="6497">Glycosylated hemoglobin % (HbA</offsets><sub><offsets xml_i="12687" xml_f="12689" txt_i="6497" txt_f="6499">1c</offsets></sub><offsets xml_i="12695" xml_f="12696" txt_i="6499" txt_f="6500">)</offsets></p></list-item><list-item><p><offsets xml_i="12726" xml_f="12774" txt_i="6501" txt_f="6549">Lipid profile, blood urea, and serum creatinine.</offsets></p></list-item></list><offsets xml_i="12797" xml_f="12798" txt_i="6550" txt_f="6551">
</offsets></p></sec><sec id="sec2-5"><title><offsets xml_i="12832" xml_f="12855" txt_i="6553" txt_f="6576">Criteria for assessment</offsets></title><p><offsets xml_i="12866" xml_f="13239" txt_i="6577" txt_f="6950">Assessment was done on the basis of improvement in the clinical symptoms (polyuria, polydipsia, polyphagia, weakness, burning sensation and numbness, joint pain, cramps, weight loss, loss of libido) with the help of suitable scoring method (0–3). Under the objective parameters, biochemical investigations (FBS, PPBS, glycosylated hemoglobin, lipid profile) have been done.</offsets></p><p><offsets xml_i="13246" xml_f="13319" txt_i="6951" txt_f="7024">The data of all the patients were assessed statistically by using paired </offsets><italic><offsets xml_i="13327" xml_f="13328" txt_i="7024" txt_f="7025">t</offsets></italic><offsets xml_i="13337" xml_f="13396" txt_i="7025" txt_f="7084">-test in both groups. For inter-group comparison, unpaired </offsets><italic><offsets xml_i="13404" xml_f="13405" txt_i="7084" txt_f="7085">t</offsets></italic><offsets xml_i="13414" xml_f="13429" txt_i="7085" txt_f="7100">-test was used.</offsets></p></sec><sec id="sec2-6"><title><offsets xml_i="13463" xml_f="13521" txt_i="7102" txt_f="7160">Criteria for assessment of overall improvement in symptoms</offsets></title><p><offsets xml_i="13532" xml_f="13646" txt_i="7161" txt_f="7275">To determine overall improvement based on all the symptoms, a criteria was defined. Number of symptoms absent at 3</offsets><sup><offsets xml_i="13651" xml_f="13653" txt_i="7275" txt_f="7277">rd</offsets></sup><offsets xml_i="13659" xml_f="13785" txt_i="7277" txt_f="7403"> follow-up as compared to before treatment (in percentage) was used to define it as overall criteria for improvement as below:</offsets></p><p><offsets xml_i="13792" xml_f="13793" txt_i="7404" txt_f="7405">
</offsets><list list-type="order"><list-item><p><offsets xml_i="13831" xml_f="13856" txt_i="7405" txt_f="7430">Complete improvement 100%</offsets></p></list-item><list-item><p><offsets xml_i="13886" xml_f="13920" txt_i="7431" txt_f="7462">Marked improvement 75% to &lt;100%</offsets></p></list-item><list-item><p><offsets xml_i="13950" xml_f="13985" txt_i="7463" txt_f="7495">Moderate improvement 50% to &lt;75%</offsets></p></list-item><list-item><p><offsets xml_i="14015" xml_f="14044" txt_i="7496" txt_f="7522">Mild improvement 1 to &lt;50%</offsets></p></list-item><list-item><p><offsets xml_i="14074" xml_f="14092" txt_i="7523" txt_f="7541">No improvement 0%.</offsets></p></list-item></list><offsets xml_i="14115" xml_f="14116" txt_i="7542" txt_f="7543">
</offsets></p></sec></sec><sec id="sec1-3"><title><offsets xml_i="14156" xml_f="14180" txt_i="7546" txt_f="7570">Observations and Results</offsets></title><p><offsets xml_i="14191" xml_f="14644" txt_i="7571" txt_f="8024">In this study, maximum cases (36.66%) were from the age group of 51–60 years, 63.33% were males, 77.78% were Hindus, 42.22% were graduates, 43.33% were servicemen, and 93.33% were married. Maximum cases (71.11%) were from middle socioeconomic group, 75.55% were from urban community, and 55.56% were belonging to mixed dietary habit. About 53.34% patients had negative family history and 46.67% were not having any addiction. Nearly, 55.56% were having </offsets><italic><offsets xml_i="14652" xml_f="14673" txt_i="8024" txt_f="8045">Kaphapittaja Prakriti</offsets></italic><offsets xml_i="14682" xml_f="14706" txt_i="8045" txt_f="8069"> and 62.22% were having </offsets><italic><offsets xml_i="14714" xml_f="14737" txt_i="8069" txt_f="8092">Rajasika Manas Prakriti</offsets></italic><offsets xml_i="14746" xml_f="14839" txt_i="8092" txt_f="8182">. In the study, maximum chronicity was &gt;1–3 years (25.55%). Among the chief complaints of </offsets><italic><offsets xml_i="14847" xml_f="14854" txt_i="8182" txt_f="8189">Prameha</offsets></italic><offsets xml_i="14863" xml_f="15195" txt_i="8189" txt_f="8521">, 83.75% patients had generalized weakness, 81.12% patients had burning sensation and numbness, 78.75% patients had polyuria, 76.25% patients had polydipsia, 73.75% patients had polyphagia, 51.25% patients had joint pain, 43.75% patients had loss of libido, 38.75% patients had cramps on walking, and 30.0% patients had weight loss.</offsets></p><p><offsets xml_i="15202" xml_f="15616" txt_i="8522" txt_f="8936">In Group A, 79.62% of the patients had symptomatic relief in case of polyuria, 74.48% relief in polyphagia, 80.76% relief in polydipsia, 79.23% relief in generalized weakness, 75.79% relief in burning sensation and numbness, 83.33% relief in joint pain, 85.45% relief in cramps, 86.84% relief in weight loss, and 92.85% relief in loss of libido. The relief was statistically highly significant in all the symptoms.</offsets></p><p><offsets xml_i="15623" xml_f="15883" txt_i="8937" txt_f="9197">Group B provided 69.03% improvement in polyuria, 70.34% in polyphagia, 77.44% in polydipsia, 75.48% in generalized weakness, 76.47% in burning sensation and numbness, 87.50% in joint pain, 94.33% in cramps, 91.89% in weight loss, and 79.31% in loss of libido [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="15915" xml_f="15922" txt_i="9197" txt_f="9204">Table 1</offsets></xref><offsets xml_i="15929" xml_f="15931" txt_i="9204" txt_f="9206">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="15979" xml_f="15986" txt_i="9207" txt_f="9214">Table 1</offsets></label><caption><p><offsets xml_i="16006" xml_f="16060" txt_i="9214" txt_f="9268">Effect of trial drugs on symptoms of diabetes mellitus</offsets></p></caption><graphic xlink:href="AYU-37-120-g001"></graphic></table-wrap><sec id="sec2-7"><title><offsets xml_i="16159" xml_f="16184" txt_i="9269" txt_f="9294">Overall effect of therapy</offsets></title><p><offsets xml_i="16195" xml_f="16589" txt_i="9295" txt_f="9689">In Group A, 15% of the cases had complete improvement in the symptoms and 30% cases had marked improvement. Patients with moderate improvement and mild improvement were 40% and 12.5%, respectively. In Group B, 10% of the cases had complete improvement in the symptoms and 30% cases had marked improvement. Patients with moderate improvement and mild improvement were 35% and 25%, respectively [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="16621" xml_f="16628" txt_i="9689" txt_f="9696">Table 2</offsets></xref><offsets xml_i="16635" xml_f="16637" txt_i="9696" txt_f="9698">].</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="16685" xml_f="16692" txt_i="9699" txt_f="9706">Table 2</offsets></label><caption><p><offsets xml_i="16712" xml_f="16774" txt_i="9706" txt_f="9768">Overall effect of therapy on the symptoms of diabetes mellitus</offsets></p></caption><graphic xlink:href="AYU-37-120-g002"></graphic></table-wrap><p><offsets xml_i="16852" xml_f="16965" txt_i="9769" txt_f="9882">FBS and PPBS reduced by 24.01% and 20.23%, respectively, in Group A, which was statistically highly significant (</offsets><italic><offsets xml_i="16973" xml_f="16974" txt_i="9882" txt_f="9883">P</offsets></italic><offsets xml_i="16983" xml_f="17121" txt_i="9883" txt_f="10018"> &lt; 0.001). In Group B, reduction in FBS and PPBS was 26.03% and 19.29%, respectively, which was also statistically highly significant (</offsets><italic><offsets xml_i="17129" xml_f="17130" txt_i="10018" txt_f="10019">P</offsets></italic><offsets xml_i="17139" xml_f="17153" txt_i="10019" txt_f="10030"> &lt; 0.001) [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="17185" xml_f="17192" txt_i="10030" txt_f="10037">Table 3</offsets></xref><offsets xml_i="17199" xml_f="17204" txt_i="10037" txt_f="10042"> and </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="17234" xml_f="17242" txt_i="10042" txt_f="10050">Figure 1</offsets></xref><offsets xml_i="17249" xml_f="17351" txt_i="10050" txt_f="10152">]. Statistically significant reduction was found in glycosylated hemoglobin percentage in both groups.</offsets></p><table-wrap id="T3" position="float"><label><offsets xml_i="17399" xml_f="17406" txt_i="10153" txt_f="10160">Table 3</offsets></label><caption><p><offsets xml_i="17426" xml_f="17492" txt_i="10160" txt_f="10226">Effect of trial drugs on blood sugar level in patients of diabetes</offsets></p></caption><graphic xlink:href="AYU-37-120-g003"></graphic></table-wrap><fig id="F1" position="float"><label><offsets xml_i="17604" xml_f="17612" txt_i="10227" txt_f="10235">Figure 1</offsets></label><caption><p><offsets xml_i="17632" xml_f="17704" txt_i="10235" txt_f="10307">Mean percentage fall in blood sugar levels after completion of treatment</offsets></p></caption><graphic xlink:href="AYU-37-120-g004"></graphic></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="17830" xml_f="17840" txt_i="10310" txt_f="10320">Discussion</offsets></title><p><offsets xml_i="17851" xml_f="17878" txt_i="10321" txt_f="10348">In the etiopathogenesis of </offsets><italic><offsets xml_i="17886" xml_f="17895" txt_i="10348" txt_f="10357">Madhumeha</offsets></italic><offsets xml_i="17904" xml_f="17920" txt_i="10357" txt_f="10373">, all the three </offsets><italic><offsets xml_i="17928" xml_f="17934" txt_i="10373" txt_f="10379">Doshas</offsets></italic><offsets xml_i="17943" xml_f="17952" txt_i="10379" txt_f="10388"> and ten </offsets><italic><offsets xml_i="17960" xml_f="17967" txt_i="10388" txt_f="10395">Dushyas</offsets></italic><offsets xml_i="17976" xml_f="17994" txt_i="10395" txt_f="10413"> get vitiated but </offsets><italic><offsets xml_i="18002" xml_f="18012" txt_i="10413" txt_f="10423">Vata Dosha</offsets></italic><offsets xml_i="18021" xml_f="18026" txt_i="10423" txt_f="10428"> and </offsets><italic><offsets xml_i="18034" xml_f="18037" txt_i="10428" txt_f="10431">Oja</offsets></italic><offsets xml_i="18046" xml_f="18067" txt_i="10431" txt_f="10452"> (essence of all the </offsets><italic><offsets xml_i="18075" xml_f="18081" txt_i="10452" txt_f="10458">Dhatus</offsets></italic><offsets xml_i="18090" xml_f="18127" txt_i="10458" txt_f="10495">) are the main factors. Vitiation of </offsets><italic><offsets xml_i="18135" xml_f="18139" txt_i="10495" txt_f="10499">Vata</offsets></italic><offsets xml_i="18148" xml_f="18173" txt_i="10499" txt_f="10524"> may occur either due to </offsets><italic><offsets xml_i="18181" xml_f="18192" txt_i="10524" txt_f="10535">Dhatukshaya</offsets></italic><offsets xml_i="18201" xml_f="18212" txt_i="10535" txt_f="10546"> or due to </offsets><italic><offsets xml_i="18220" xml_f="18227" txt_i="10546" txt_f="10553">Avarana</offsets></italic><offsets xml_i="18236" xml_f="18240" txt_i="10553" txt_f="10557"> of </offsets><italic><offsets xml_i="18248" xml_f="18252" txt_i="10557" txt_f="10561">Vata</offsets></italic><offsets xml_i="18261" xml_f="18269" txt_i="10561" txt_f="10569"> by the </offsets><italic><offsets xml_i="18277" xml_f="18283" txt_i="10569" txt_f="10575">Doshas</offsets></italic><offsets xml_i="18292" xml_f="18294" txt_i="10575" txt_f="10577"> (</offsets><italic><offsets xml_i="18302" xml_f="18307" txt_i="10577" txt_f="10582">Kapha</offsets></italic><offsets xml_i="18316" xml_f="18318" txt_i="10582" txt_f="10584">, </offsets><italic><offsets xml_i="18326" xml_f="18331" txt_i="10584" txt_f="10589">Pitta</offsets></italic><offsets xml_i="18340" xml_f="18342" txt_i="10589" txt_f="10591">, </offsets><italic><offsets xml_i="18350" xml_f="18354" txt_i="10591" txt_f="10595">Meda</offsets></italic><offsets xml_i="18363" xml_f="18369" txt_i="10595" txt_f="10601">, and </offsets><italic><offsets xml_i="18377" xml_f="18382" txt_i="10601" txt_f="10606">Mamsa</offsets></italic><offsets xml_i="18391" xml_f="18394" txt_i="10606" txt_f="10609">).[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="18427" xml_f="18428" txt_i="10609" txt_f="10610">3</offsets></xref><offsets xml_i="18435" xml_f="18532" txt_i="10610" txt_f="10707">] Hence, in its management, such drugs are to be selected which can maintain the normal state of </offsets><italic><offsets xml_i="18540" xml_f="18544" txt_i="10707" txt_f="10711">Agni</offsets></italic><offsets xml_i="18553" xml_f="18570" txt_i="10711" txt_f="10728"> and removes the </offsets><italic><offsets xml_i="18578" xml_f="18585" txt_i="10728" txt_f="10735">Avarana</offsets></italic><offsets xml_i="18594" xml_f="18598" txt_i="10735" txt_f="10739"> of </offsets><italic><offsets xml_i="18606" xml_f="18610" txt_i="10739" txt_f="10743">Vata</offsets></italic><offsets xml_i="18619" xml_f="18631" txt_i="10743" txt_f="10755"> along with </offsets><italic><offsets xml_i="18639" xml_f="18647" txt_i="10755" txt_f="10763">Rasayana</offsets></italic><offsets xml_i="18656" xml_f="18666" txt_i="10763" txt_f="10773"> property.</offsets></p><p><italic><offsets xml_i="18681" xml_f="18690" txt_i="10774" txt_f="10783">Shilajatu</offsets></italic><offsets xml_i="18699" xml_f="18710" txt_i="10783" txt_f="10794"> is having </offsets><italic><offsets xml_i="18718" xml_f="18723" txt_i="10794" txt_f="10799">Tikta</offsets></italic><offsets xml_i="18732" xml_f="18734" txt_i="10799" txt_f="10801">, </offsets><italic><offsets xml_i="18742" xml_f="18746" txt_i="10801" txt_f="10805">Katu</offsets></italic><offsets xml_i="18755" xml_f="18761" txt_i="10805" txt_f="10811">, and </offsets><italic><offsets xml_i="18769" xml_f="18781" txt_i="10811" txt_f="10823">Kashaya Rasa</offsets></italic><offsets xml_i="18790" xml_f="18792" txt_i="10823" txt_f="10825">, </offsets><italic><offsets xml_i="18800" xml_f="18811" txt_i="10825" txt_f="10836">Katu Vipaka</offsets></italic><offsets xml_i="18820" xml_f="18822" txt_i="10836" txt_f="10838">, </offsets><italic><offsets xml_i="18830" xml_f="18841" txt_i="10838" txt_f="10849">Ushna Virya</offsets></italic><offsets xml_i="18850" xml_f="18852" txt_i="10849" txt_f="10851">, </offsets><italic><offsets xml_i="18860" xml_f="18867" txt_i="10851" txt_f="10858">Rechaka</offsets></italic><offsets xml_i="18876" xml_f="18878" txt_i="10858" txt_f="10860">, </offsets><italic><offsets xml_i="18886" xml_f="18894" txt_i="10860" txt_f="10868">Shoshana</offsets></italic><offsets xml_i="18903" xml_f="18909" txt_i="10868" txt_f="10874">, and </offsets><italic><offsets xml_i="18917" xml_f="18924" txt_i="10874" txt_f="10881">Chedana</offsets></italic><offsets xml_i="18933" xml_f="18946" txt_i="10881" txt_f="10894"> properties.[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="18979" xml_f="18980" txt_i="10894" txt_f="10895">4</offsets></xref><offsets xml_i="18987" xml_f="18996" txt_i="10895" txt_f="10904">] It has </offsets><italic><offsets xml_i="19004" xml_f="19012" txt_i="10904" txt_f="10912">Rasayana</offsets></italic><offsets xml_i="19021" xml_f="19023" txt_i="10912" txt_f="10914">, </offsets><italic><offsets xml_i="19031" xml_f="19038" txt_i="10914" txt_f="10921">Vrishya</offsets></italic><offsets xml_i="19047" xml_f="19053" txt_i="10921" txt_f="10927">, and </offsets><italic><offsets xml_i="19061" xml_f="19071" txt_i="10927" txt_f="10937">Pramehagna</offsets></italic><offsets xml_i="19080" xml_f="19096" txt_i="10937" txt_f="10953"> property also. </offsets><italic><offsets xml_i="19104" xml_f="19113" txt_i="10953" txt_f="10962">Shilajatu</offsets></italic><offsets xml_i="19122" xml_f="19131" txt_i="10962" txt_f="10971"> acts on </offsets><italic><offsets xml_i="19139" xml_f="19143" txt_i="10971" txt_f="10975">Agni</offsets></italic><offsets xml_i="19152" xml_f="19187" txt_i="10975" txt_f="11010"> (maintain the excellent status of </offsets><italic><offsets xml_i="19195" xml_f="19199" txt_i="11010" txt_f="11014">Agni</offsets></italic><offsets xml_i="19208" xml_f="19214" txt_i="11014" txt_f="11020">) and </offsets><italic><offsets xml_i="19222" xml_f="19228" txt_i="11020" txt_f="11026">Srotas</offsets></italic><offsets xml_i="19237" xml_f="19319" txt_i="11026" txt_f="11108"> (removes the blockage of microchannels leading to better perfusion of tissue) by </offsets><italic><offsets xml_i="19327" xml_f="19338" txt_i="11108" txt_f="11119">Katu Vipaka</offsets></italic><offsets xml_i="19347" xml_f="19352" txt_i="11119" txt_f="11124"> and </offsets><italic><offsets xml_i="19360" xml_f="19371" txt_i="11124" txt_f="11135">Ushna Virya</offsets></italic><offsets xml_i="19380" xml_f="19405" txt_i="11135" txt_f="11160">. It reduces quantity of </offsets><italic><offsets xml_i="19413" xml_f="19418" txt_i="11160" txt_f="11165">Kapha</offsets></italic><offsets xml_i="19427" xml_f="19429" txt_i="11165" txt_f="11167">, </offsets><italic><offsets xml_i="19437" xml_f="19441" txt_i="11167" txt_f="11171">Meda</offsets></italic><offsets xml_i="19450" xml_f="19456" txt_i="11171" txt_f="11177">, and </offsets><italic><offsets xml_i="19464" xml_f="19469" txt_i="11177" txt_f="11182">Kleda</offsets></italic><offsets xml_i="19478" xml_f="19512" txt_i="11182" txt_f="11216"> by its properties. Moreover, the </offsets><italic><offsets xml_i="19520" xml_f="19528" txt_i="11216" txt_f="11224">Rasayana</offsets></italic><offsets xml_i="19537" xml_f="19550" txt_i="11224" txt_f="11237"> property of </offsets><italic><offsets xml_i="19558" xml_f="19567" txt_i="11237" txt_f="11246">Shilajatu</offsets></italic><offsets xml_i="19576" xml_f="19700" txt_i="11246" txt_f="11370"> nourishes the body, helps to keep the body tissue in healthy state, and improves the metabolism at each and every level of </offsets><italic><offsets xml_i="19708" xml_f="19713" txt_i="11370" txt_f="11375">Dhatu</offsets></italic><offsets xml_i="19722" xml_f="19782" txt_i="11375" txt_f="11435">. In various pharmacological studies, it has been seen that </offsets><italic><offsets xml_i="19790" xml_f="19799" txt_i="11435" txt_f="11444">Shilajatu</offsets></italic><offsets xml_i="19808" xml_f="19854" txt_i="11444" txt_f="11490"> can prevent maturity onset diabetes mellitus[</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="19887" xml_f="19888" txt_i="11490" txt_f="11491">5</offsets></xref><offsets xml_i="19895" xml_f="19968" txt_i="11491" txt_f="11564">] and is effective in controlling blood glucose level and lipid profile.[</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="20001" xml_f="20002" txt_i="11564" txt_f="11565">6</offsets></xref><offsets xml_i="20009" xml_f="20010" txt_i="11565" txt_f="11566">]</offsets></p><p><offsets xml_i="20017" xml_f="20020" txt_i="11567" txt_f="11570">In </offsets><italic><offsets xml_i="20028" xml_f="20046" txt_i="11570" txt_f="11588">Asanadi Ghana Vati</offsets></italic><offsets xml_i="20055" xml_f="20092" txt_i="11588" txt_f="11625">, most of the ingredients are having </offsets><italic><offsets xml_i="20100" xml_f="20107" txt_i="11625" txt_f="11632">Kashaya</offsets></italic><offsets xml_i="20116" xml_f="20121" txt_i="11632" txt_f="11637"> and </offsets><italic><offsets xml_i="20129" xml_f="20139" txt_i="11637" txt_f="11647">Tikta Rasa</offsets></italic><offsets xml_i="20148" xml_f="20150" txt_i="11647" txt_f="11649">, </offsets><italic><offsets xml_i="20158" xml_f="20163" txt_i="11649" txt_f="11654">Laghu</offsets></italic><offsets xml_i="20172" xml_f="20177" txt_i="11654" txt_f="11659"> and </offsets><italic><offsets xml_i="20185" xml_f="20196" txt_i="11659" txt_f="11670">Ruksha Guna</offsets></italic><offsets xml_i="20205" xml_f="20260" txt_i="11670" txt_f="11725">. All the drugs in this polyherbal compound are having </offsets><italic><offsets xml_i="20268" xml_f="20279" txt_i="11725" txt_f="11736">Katu Vipaka</offsets></italic><offsets xml_i="20288" xml_f="20326" txt_i="11736" txt_f="11774"> and majority of the drugs possess of </offsets><italic><offsets xml_i="20334" xml_f="20353" txt_i="11774" txt_f="11793">Kapha-Pitta Shamaka</offsets></italic><offsets xml_i="20362" xml_f="20373" txt_i="11793" txt_f="11804"> property. </offsets><italic><offsets xml_i="20381" xml_f="20399" txt_i="11804" txt_f="11822">Asanadi Ghana Vati</offsets></italic><offsets xml_i="20408" xml_f="20429" txt_i="11822" txt_f="11843"> scrap out excessive </offsets><italic><offsets xml_i="20437" xml_f="20442" txt_i="11843" txt_f="11848">Kapha</offsets></italic><offsets xml_i="20451" xml_f="20456" txt_i="11848" txt_f="11853"> and </offsets><italic><offsets xml_i="20464" xml_f="20468" txt_i="11853" txt_f="11857">Meda</offsets></italic><offsets xml_i="20477" xml_f="20483" txt_i="11857" txt_f="11863"> from </offsets><italic><offsets xml_i="20491" xml_f="20497" txt_i="11863" txt_f="11869">Srotas</offsets></italic><offsets xml_i="20506" xml_f="20510" txt_i="11869" txt_f="11873"> by </offsets><italic><offsets xml_i="20518" xml_f="20525" txt_i="11873" txt_f="11880">Kashaya</offsets></italic><offsets xml_i="20534" xml_f="20539" txt_i="11880" txt_f="11885"> and </offsets><italic><offsets xml_i="20547" xml_f="20557" txt_i="11885" txt_f="11895">Tikta Rasa</offsets></italic><offsets xml_i="20566" xml_f="20568" txt_i="11895" txt_f="11897">. </offsets><italic><offsets xml_i="20576" xml_f="20581" txt_i="11897" txt_f="11902">Laghu</offsets></italic><offsets xml_i="20590" xml_f="20595" txt_i="11902" txt_f="11907"> and </offsets><italic><offsets xml_i="20603" xml_f="20614" txt_i="11907" txt_f="11918">Ruksha Guna</offsets></italic><offsets xml_i="20623" xml_f="20642" txt_i="11918" txt_f="11937"> absorb the excess </offsets><italic><offsets xml_i="20650" xml_f="20655" txt_i="11937" txt_f="11942">Kapha</offsets></italic><offsets xml_i="20664" xml_f="20666" txt_i="11942" txt_f="11944">, </offsets><italic><offsets xml_i="20674" xml_f="20678" txt_i="11944" txt_f="11948">Meda</offsets></italic><offsets xml_i="20687" xml_f="20693" txt_i="11948" txt_f="11954">, and </offsets><italic><offsets xml_i="20701" xml_f="20706" txt_i="11954" txt_f="11959">Kleda</offsets></italic><offsets xml_i="20715" xml_f="20764" txt_i="11959" txt_f="12008"> and improve the consistency of tissue elements. </offsets><italic><offsets xml_i="20772" xml_f="20783" txt_i="12008" txt_f="12019">Katu Vipaka</offsets></italic><offsets xml_i="20792" xml_f="20806" txt_i="12019" txt_f="12033"> enhances the </offsets><italic><offsets xml_i="20814" xml_f="20818" txt_i="12033" txt_f="12037">Agni</offsets></italic><offsets xml_i="20827" xml_f="20880" txt_i="12037" txt_f="12090"> (normalizes the metabolic processes) and remove the </offsets><italic><offsets xml_i="20888" xml_f="20895" txt_i="12090" txt_f="12097">Avarana</offsets></italic><offsets xml_i="20904" xml_f="20922" txt_i="12097" txt_f="12115"> (obstruction) of </offsets><italic><offsets xml_i="20930" xml_f="20934" txt_i="12115" txt_f="12119">Vata</offsets></italic><offsets xml_i="20943" xml_f="21039" txt_i="12119" txt_f="12215">. Moreover, in various pharmacological studies, it has been proved that almost all the drugs of </offsets><italic><offsets xml_i="21047" xml_f="21059" txt_i="12215" txt_f="12227">Asanadi Gana</offsets></italic><offsets xml_i="21068" xml_f="21099" txt_i="12227" txt_f="12258"> have antidiabetic properties.[</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="21132" xml_f="21133" txt_i="12258" txt_f="12259">7</offsets></xref><offsets xml_i="21140" xml_f="21141" txt_i="12259" txt_f="12260">]</offsets></p><p><offsets xml_i="21148" xml_f="21196" txt_i="12261" txt_f="12309">Overall therapeutic effects of both test drugs (</offsets><italic><offsets xml_i="21204" xml_f="21213" txt_i="12309" txt_f="12318">Shilajatu</offsets></italic><offsets xml_i="21222" xml_f="21227" txt_i="12318" txt_f="12323"> and </offsets><italic><offsets xml_i="21235" xml_f="21253" txt_i="12323" txt_f="12341">Asanadi Ghana Vati</offsets></italic><offsets xml_i="21262" xml_f="21468" txt_i="12341" txt_f="12547">) were found statistically significant in all the symptoms when compared with initial and follow up. On objective parameters, both drugs showed significant decrease in FBS, PPBS and glycosylated hemoglobin.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="21524" xml_f="21534" txt_i="12549" txt_f="12559">Conclusion</offsets></title><p><offsets xml_i="21545" xml_f="21613" txt_i="12560" txt_f="12628">Although both groups showed significant relief in all the symptoms, </offsets><italic><offsets xml_i="21621" xml_f="21630" txt_i="12628" txt_f="12637">Shilajatu</offsets></italic><offsets xml_i="21639" xml_f="21674" txt_i="12637" txt_f="12672"> provided overall more relief than </offsets><italic><offsets xml_i="21682" xml_f="21700" txt_i="12672" txt_f="12690">Asanadi Ghana Vati</offsets></italic><offsets xml_i="21709" xml_f="21765" txt_i="12690" txt_f="12746">. The reduction in FBS level was found slightly more by </offsets><italic><offsets xml_i="21773" xml_f="21791" txt_i="12746" txt_f="12764">Asanadi Ghana Vati</offsets></italic><offsets xml_i="21800" xml_f="21862" txt_i="12764" txt_f="12826"> while the reduction in PPBS level was found slightly more by </offsets><italic><offsets xml_i="21870" xml_f="21879" txt_i="12826" txt_f="12835">Shilajatu</offsets></italic><offsets xml_i="21888" xml_f="22009" txt_i="12835" txt_f="12956">. Moreover, any adverse effects were not reported during the clinical trial of 3 months. Hence, the present trial drugs (</offsets><italic><offsets xml_i="22017" xml_f="22026" txt_i="12956" txt_f="12965">Shilajatu</offsets></italic><offsets xml_i="22035" xml_f="22040" txt_i="12965" txt_f="12970"> and </offsets><italic><offsets xml_i="22048" xml_f="22066" txt_i="12970" txt_f="12988">Asanadi Ghana Vati</offsets></italic><offsets xml_i="22075" xml_f="22140" txt_i="12988" txt_f="13053">) seem to be effective and completely safe for the management of </offsets><italic><offsets xml_i="22148" xml_f="22157" txt_i="13053" txt_f="13062">Madhumeha</offsets></italic><offsets xml_i="22166" xml_f="22194" txt_i="13062" txt_f="13090"> (type-2 diabetes mellitus).</offsets></p><sec id="sec2-8"><title><offsets xml_i="22222" xml_f="22255" txt_i="13091" txt_f="13124">Financial support and sponsorship</offsets></title><p><offsets xml_i="22266" xml_f="22270" txt_i="13125" txt_f="13129">Nil.</offsets></p></sec><sec id="sec2-9" sec-type="COI-statement"><title><offsets xml_i="22329" xml_f="22350" txt_i="13131" txt_f="13152">Conflicts of interest</offsets></title><p><offsets xml_i="22361" xml_f="22396" txt_i="13153" txt_f="13188">There are no conflicts of interest.</offsets></p></sec></sec></body><back><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>J</given-names></name></person-group><source>Ashtanga Samgraha of Vriddha Vagbhatta, Sutra Sthana</source><year>2008</year><edition>2nd ed</edition><issue>Ch. 16, Ver. 13-14</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chowkhambha Sanskrita Series Office</publisher-name><fpage>133</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upadhyaya</surname><given-names>Yadunandana</given-names></name></person-group><source>Ashtanga Hridaya of Vagbhatta, Sutra Sthana</source><year>2009</year><edition>2nd ed</edition><issue>2. Che. 15, Ver. 19-20</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chowkhambha Prakashana</publisher-name><fpage>105</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Gupta</surname><given-names>Kaviraja Atrideva</given-names></name></person-group><source>Astanga Hridayam of Vagbhatta, Nidana Sthana</source><year>2005</year><edition>3rd ed</edition><issue>Ch. 10, Ver. 18-19</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhambha Sanskrita Sansthana</publisher-name><fpage>255</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shastri</surname><given-names>Kaviraj Ambikadutta</given-names></name></person-group><source>Sushruta Samhita of Susruta, Chikitsa Sthana</source><year>2002</year><edition>13th ed</edition><issue>Che. 13, Ver. 8-9</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Sansthana</publisher-name><fpage>65</fpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>SK</given-names></name></person-group><article-title>Shilajit attenuates streptozotocin induced diabetes mellitus and decrease in pancreatic islet superoxide dismutase activity in rats</article-title><source>Phytother Res</source><year>1995</year><volume>9</volume><fpage>41</fpage><lpage>4</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname><given-names>NA</given-names></name><name><surname>Mazumdar</surname><given-names>B</given-names></name><name><surname>Bhatt</surname><given-names>JD</given-names></name><name><surname>Hemavathi</surname><given-names>KG</given-names></name></person-group><article-title>Effect of shilajit on blood glucose and lipid profile in alloxan-induced diabetic rats</article-title><source>Indian J Pharmacol</source><year>2004</year><volume>36</volume><fpage>373</fpage><lpage>6</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Keshari</surname><given-names>B.B</given-names></name><name><surname>Tiwari</surname><given-names>S.K</given-names></name><name><surname>Murthy</surname><given-names>K.H.H.V.S.S.N</given-names></name></person-group><article-title>A Review on Antidiabetic Action of Asanadi Gana</article-title><source>Int J Res Ayurveda Pharm</source><year>2013</year><volume>4</volume><fpage>638</fpage><lpage>46</lpage></element-citation></ref></ref-list></back></article>